NeuBase Therapeutics Reports Financial Results for the Third Quarter of Fiscal Year 2021 and Recent Operating Highlights

NEXT STORY
NeuroPace Reports Second Quarter 2021 Financial Results
PREV STORY
Pest Control Market To Touch USD 31.94 Billion at CAGR 6.31% Forecast Till 2027; Exclusive Fortune Business Insights™
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Marinus Pharmaceuticals Appoints Sasha Damouni Ellis as Vice President, Investor Relations and Corporate Communications

author_avatar
NASDAQ Market News

Morphic Announces Corporate Highlights and Second Quarter 2021 Financial Results

author_avatar
NASDAQ Market News

Batavia Biosciences to deploy Horizon Discovery’s CHO cell technology to develop anti-Zika biotherapeutic with Vanderbilt University Medical Center and IDBiologics

author_avatar
NASDAQ Market News